Navigation Links
Critical Alerts for CVX, DOW, AA, ISRG, and CELG Released by Seven Summits Research

CHICAGO, June 3 /PRNewswire/ -- Seven Summits Research issues PriceWatch Alerts for key stocks.

Seven Summits Strategic Investments' PriceWatch Alerts are available at (Note: You may have to copy this link into your browser then press the [ENTER] key.)

Today's PriceWatch Alerts cover the following stocks: Chevron Corp. (NYSE: CVX), Dow Chemical (NYSE: DOW), Alcoa, Inc. (NYSE: AA), Intuitive Surgical, Inc. (Nasdaq: ISRG), and Celgene Corporation (Nasdaq: CELG).

In today's unsure markets these brief PriceWatch Alerts contain concise detailed strategies for each covered stock and include position protection tactics designed to potentially defend investors from unexpected market shifts. While other market reports only provide stock news and opinion, we offer strategies that position investments against uncertainty and increase chances of making a profit, even if a stock goes down.

"Our PriceWatch Alerts go beyond other market reports. Along with a brief concise overview, each PriceWatch Alert provides useful strategies, which ensure potential investments are protected with basic hedging techniques," says Reid Stratton, Seven Summits Senior Analyst. "These brief company reports contain information that can benefit expert and novice investors who want to stay ahead of the market."

For essential information on stocks poised to move go to: for Seven Summits Strategic Investments' PriceWatch Alerts.

Seven Summits Investment Research is an independent investment research group, which focuses on the U.S. equities and options markets. Our analytical tools, screening techniques, rigorous research methods and committed staff provide solid information to help our clients make the best possible investment decisions. For more information go to CRD# 137114

Free Report: 3 Stocks to Help Rebuild Your Wealth. It's time to start making money in the stock market again! You CAN find plenty of profits even in these uncertain times. Many low-priced stocks are truly undervalued and it's only a matter of time before they're discovered and the stock takes off. See how you can profit from bulletproof stocks that grow earnings even in tough times. Find out the 3 'buried treasure' stocks that can help you rebuild your wealth now! Click here now.

All stocks and options shown are examples only - not recommendations to buy or sell. Our picks do not represent a positive or negative outlook on any security. Potential returns do not take into account your trade size, brokerage commissions or taxes - expenses that will affect actual investment returns. Stocks and options involve risk, thus they are not suitable for all investors. Prior to buying or selling options, a person should request a copy of Characteristics and Risks of Standardized Options available from Catherine at 800-698-9101 or at Privacy policy available upon request.

SOURCE Seven Summits Investment Research
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. MedSolutions: Accurate Diagnosis Is Critical to Reducing Healthcare Costs
2. Not On Our Watch Grant to UNICEF to Support Critical Protection Programs for Zimbabwean Refugee Children
3. Health Education Solutions Launches Online Certification Programs for Critical Care Medical Professionals
4. FDA ignores critical information on home HIV tests
5. Scottish Widows Releases Critical Illness Cover Claims Figures
6. Reducing Chronic Diseases Critical to Economic Recovery and Health Reform
7. Maryland ICU Patients Connected to Remote Critical Care Staff, Improving Quality and Safety
8. CriticalPoint(TM) Training Rated Excellent in Customer Satisfaction
9. Baier Media Room Advances Critical Care At Children's National Medical Center
10. Top 10 Hospital Technologies: C-Suite Watch List for 2009 and Beyond; Exclusive Insight on Critical Capital Decisions in ECRI Institute White Paper Available for Free Download
11. Guardian Highlights Significance of Critical Illness Insurance During National Stroke Awareness Month
Post Your Comments:
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... ... 25, 2016 , ... Dr. Calvin Johnson has dedicated his ... implemented orthobiologic procedures as a method for treating his patients. The procedure is ... to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use to help ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... ... Marcy was in a crisis. Her son James, eight, was out of control. Prone to ... , “When something upset him, he couldn’t control his emotions,” remembers Marcy. “If there ... my other children and say he was going to kill them. If we were ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with ... Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that ... PCT (procalcitonin) assay as a dedicated testing solution for ... clearance, Roche is the first IVD company in the ... risk assessment and management. PCT is a ... in blood can aid clinicians in assessing the risk ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
Breaking Medicine Technology: